Role of immunologic cross-reactivity in neurological diseases

Neurological Research

Volumn 27, Issue 7, 2005, Pages 726-733

  Ercolini, Anne M ^a   Miller, Stephen D ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Autoimmunity; Disease models; Immunology; Molecular mimicry

Indexed keywords

ALPHA ACTININ; AUTOANTIBODY; BRAIN PROTEIN; CEREBROSIDE; CHOLINERGIC RECEPTOR; GANGLIOSIDE; MYELIN; RETINA S ANTIGEN; RIBONUCLEOPROTEIN;

AUTOIMMUNITY; BASAL GANGLION; BORRELIA BURGDORFERI; BORRELIA INFECTION; CENTRAL NERVOUS SYSTEM INFECTION; CHAGAS DISEASE; DISEASE ASSOCIATION; DISEASE MODEL; GUILLAIN BARRE SYNDROME; HERPES SIMPLEX VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNE RESPONSE; MOLECULAR MIMICRY; MULTIPLE SCLEROSIS; MYASTHENIA GRAVIS; NEUROIMMUNOLOGY; NEUROLOGIC DISEASE; NONHUMAN; REVIEW; SPASTIC PARESIS; STREPTOCOCCUS PYOGENES; TRYPANOSOMA CRUZI; UVEITIS;

ANIMALS; CROSS REACTIONS; GUILLAIN-BARRE SYNDROME; HUMANS; LYME DISEASE; MODELS, NEUROLOGICAL; MULTIPLE SCLEROSIS; MYASTHENIA GRAVIS; NERVOUS SYSTEM; PARAPARESIS, TROPICAL SPASTIC;

EID: 27244441701     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164105X49508     Document Type: Review

References (103)

1. Walker PR, Calzascia T, de Tribolet N, et al. T-cell immune responses in the brain and their relevance for cerebral malignancies. Brain Res Rev 2003; 42: 97-122
2. Pachter JS, de Vries HE, Fabry Z. The blood-brain barrier and its role in immune privilege in the central nervous system. J Neuropathol Exp Neurol 2003; 62: 593-604
3. Huynh HK, Dorovini-Zis K. Effects of interferon-gamma on primary cultures of human brain microvessel endothelial cells. Am J Pathol 1993; 142: 1265-1278
4. Gloor SM, Weber A, Adachi N, et al. Interleukin-1 modulates protein tyrosine phosphatase activity and permeability of brain endothelial cells. Biochem Biophys Res Commun 1997; 239: 804-809
5. Hofman FM, Chen P, Incardona F, et al. HIV-1 tat protein induces the production of interleukin-8 by human brain-derived endothelial cells. J Neuroimmunol 1999; 94: 28-39
6. Annunziata P, Cioni C, Toneatto S, et al. HIV-1 gp120 increases the permeability of rat brain endothelium cultures by a mechanism involving substance P. AIDS 1998; 12: 2377-2385
7. Price TO, Ercal N, Nakaoke R, et al. HIV-1 viral proteins gp120 and Tat induce oxidative stress in brain endothelial cells. Brain Res 2005; 1045: 57-63
8. Willison HJ, Yuki N. Peripheral neuropathies and anti-glycolipid antibodies. Brain 2002; 125: 2591-2625
9. Steinman L. Multiple sclerosis: A coordinated immunological attack against myelin in the central nervous system. Cell 1996; 85: 299-302
10. Sun JB, Olsson T, Wang WZ, et al. Autoreactive T and B cells responding to myelin proteolipid protein in multiple sclerosis and controls, Eur J Immunol 1991; 21: 1461-1468
11. Ota K, Matsui M, Milford EL, et al. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature 1990; 346: 183-187
12. Bernard CC, de Rosbo NK. Immunopathological recognition of autoantigens in multiple sclerosis. Acta Neurol (Napoli) 1991; 13: 171-178
13. Kurtzke JF. Epidemiologic evidence for multiple sclerosis as an infection. Clin Microbiol Rev 1993; 6: 382-427
14. Kurtzke JF. Multiple sclerosis in time and space-geographic clues to cause. I Neurovirol 2000; 6 (Supple. 2): S134-S140
15. Kurtzke JF, Gudmundsson KR, Bergmann S. Multiple sclerosis in Iceland: 1. Evidence of a postwar epidemic. Neurology 1982; 32: 143-150
16. Kurtzke JF, Hyllested K. Multiple sclerosis in the Faroe Islands: I. Clinical and epidemiological features. Ann Neurol 1979; 5: 6-21
17. Olson JK, Croxford JL, Miller SD. Virus-induced autoimmunity: Potential role of viruses in initiation, perpetuation, and progression of T-cell-mediated autoimmune disease. Viral Immunol 2001; 14: 227-250
18. Fujinami RS. Can virus infections trigger autoimmune disease? J Autoimmun 2001; 16: 229-234
19. Zhang J, Raus J. Myelin basic protein-reactive T cells in multiple sclerosis: Pathologic relevance and therapeutic targeting. Cytotechnology 1994; 16: 181-187
20. Wucherpfennig KW, Zhang J, Witek C, et al. Clonal expansion and persistence of human T cells specific for an immunodominant myelin basic protein peptide. J Immunol 1994; 152: 5581-5592
21. Allegretta M, Nicklas JA, Sriram S, et al. T cells responsive to myelin basic protein in patients with multiple sclerosis. Science 1990; 247: 718-721
22. Wucherpfennig KW, Strominger JL. Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein. Cell 1995; 80: 695-705
23. Rose LM, Richards T, Alvord EC, Jr. Experimental allergic encephalomyelitis (EAE) in nonhuman primates: A model of multiple sclerosis. Lab Anim Sci 1994; 44: 508-512
24. Ufret-Vincenty RL, Quigley L, Tresser N, et al. In vivo survival of viral antigen-specific T cells that induce experimental autoimmune encephalomyelitis. J Exp Med 1998; 188: 1725-1738
25. Carrizosa AM, Nicholson LB, Farzan M, et al. Expansion by self antigen is necessary for the induction of experimental autoimmune encephalomyelitis by T cells primed with a cross-reactive environmental antigen. J Immunol 1998; 161: 3307-3314
26. Olson JK, Croxford JL, Calenoff MA, et al. A virus-induced molecular mimicry model of multiple sclerosis. J Clin Invest 2001; 108: 311-318
27. Fazakerley JK, Amor S, Webb HE. Reconstitution of Semliki forest virus infected mice, induces immune mediated pathological changes in the CNS. Clin Exp Immunol 1983; 52: 115-120
28. Mokhtarian F, Zhang Z, Shi Y, et al. Molecular mimicry between a viral peptide and a myelin oligodendrocyte glycoprotein peptide induces autoimmune demyelinating disease in mice. J Neuroimmunol 1999; 95: 43-54
29. Ruiz PJ, Carren H, Hirschberg DL, et al. Microbial epitopes act as altered peptide ligands to prevent experimental autoimmune encephalomyelitis. J Exp Med 1999; 189: 1275-1284
30. Mana P, Goodyear M, Bernard C, et al. Tolerance induction by molecular mimicry: Prevention and suppression of experimental autoimmune encephalomyelitis with the milk protein butyrophilin. Int Immunol 2004; 16: 489-499
31. Ilyas AA, Willison HJ, Quarles RH, et al. Serum antibodies to gangliosides in Guillain-Barre syndrome. Ann Neurol 1988; 23: 440-447
32. Joseph SA, Tsao CY. Guillain-Barre syndrome. Adolesc Med 2002; 13: 487-494
33. Aspinall GO, Fujimoto S, McDonald AG, et al. Lipopolysaccharides from Campylobacter jejuni associated with Guillain-Barre syndrome patients mimic human gangliosides in structure. Infect Immun 1994; 62: 2122-2125
34. Yuki N, Taki T, Takahashi M, et al. Penner's serotype 4 of Campylobacter jejuni has a lipopolysaccharide that bears a GM1 ganglioside epitope as well as one that bears a GD1 epitope. Infect Immun 1994; 62: 2101-2103
35. Ang CW, Endtz HP, Jacobs BC, et al. Campylobacter jejuni lipopolysaccharides from Guillain-Barre syndrome patients induce IgG anti-GM1 antibodies in rabbits. J Neuroimmunol 2000; 104: 133-138
36. Goodyear CS, O'Hanlon GM, Plomp JJ, et al. Monoclonal antibodies raised against Guillain-Barre syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations. J Clin Invest 1999; 104: 697-708
37. Wirguin I, Briani C, Suturkova-Milosevic L, et al. Induction of anti-GM1 ganglioside antibodies by Campylobacter jejuni lipopolysaccharides. J Neuroimmunol 1997; 78: 138-142
38. Ang CW, Laman JD, Willison HJ, et al. Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barre and Miller Fisher patients. Infect Immun 2002; 70: 1202-1208
39. Nachamkin I, Liu J, Li M, et al. Campylobacter jejuni from patients with Guillain-Barre syndrome preferentially expresses a GD(1a)-like epitope. Infect Immun 2002; 70: 5299-5303
40. Yuki N, Susuki K, Koga M, et al. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome. Proc Natl Acad Sci U S A 2004; 101: 11404-11409
41. Kusunoki S, Shiina M, Kanazawa I. Anti-Gal-C antibodies in GBS subsequent to mycoplasma infection: Evidence of molecular mimicry. Neurology 2001; 57: 736-738
42. Ang CW, Tio-Gillen AP, Groen J, et al. Cross-reactive antigalactocerebroside antibodies and mycoplasma pneumoniae infections in Guillain-Barre syndrome. J Neuroimmunol 2002; 130: 179-183
43. Susuki K, Odaka M, Mori M, et al. Acute motor axonal neuropathy after mycoplasma infection: Evidence of molecular mimicry. Neurology 2004; 62: 949-956
44. Koga M, Yuki N, Tai T, et al. Miller Fisher syndrome and Haemophilus influenzae infection. Neurology 2001; 57: 686-691
45. Mori M, Kuwabara S, Miyake M, et al. Haemophilus influenzae infection and Guillain-Barre syndrome. Brain 2000; 123 (Pt. 10): 2171-2178
46. Mori M, Kuwabara S, Miyake M, et al. Haemophilus influenzae has a GM1 ganglioside-like structure and elicits Guillain-Barre syndrome. Neurology 1999; 52: 1282-1284
47. Osame M. Pathological mechanisms of human T-cell lymphotropic virus type 1-associated myelopathy (HAM/TSP). J Neurovirol 2002; 8: 359-364
48. Jernigan M, Morcos Y, Lee SM, et al. IgG in brain correlates with clinicopathological damage in HTLV-1 associated neurologic disease. Neurology 2003; 60: 1320-1327
49. Levin MC, Krichavsky M, Berk J, et al. Neuronal molecular mimicry in immune-mediated neurologic disease. Ann Neurol 1998; 44: 87-98
50. Levin MC, Lee SM, Kalume F, et al. Autoimmunity due to molecular mimicry as a cause of neurological disease. Nat Med 2002; 8: 509-513
51. Levin MC, Lee SM, Morcos Y, et al. Cross-reactivity between immunodominant human T lymphotropic virus type 1 tax and neurons: Implications for molecular mimicry. J Infect Dis 2002; 186: 1514-1517
52. Kalume F, Lee SM, Morcos Y, et al. Molecular mimicry: Cross-reactive antibodies from patients with immune-mediated neurologic disease inhibit neuronal firing. J Neurosci Res 2004; 77: 82-89
53. Fulpius BW, Miskin R, Reich E. Antibodies from myasthenic patients that compete with cholinergic agents for binding to nicotinic receptors. Proc Natl Acad Sci U S A 1980; 77: 4326-4330
54. Safwenberg J, Hammarstrom L, Lindblom JB, et al. HLA-A, -B, -C and -D antigens in male patients with myasthenia gravis. Tissue Antigens 1978; 12: 136-142
55. Bell J, Rassenti L, Smoot S, et al. HLA-DQ beta-chain polymorphism linked to myasthenia gravis. Lancet 1986; 1: 1058-1060
56. Schwimmbeck PL, Dyrberg T, Drachman DB, et al. Molecular mimicry and myasthenia gravis. An autoantigenic site of the acetylcholine receptor alpha-subunit that has biologic activity and reacts immunochemically with herpes simplex virus. J Clin Invest 1989; 84: 1174-1180
57. Deitiker P, Ashizawa T, Atassi MZ. Antigen mimicry in autoimmune disease. Can immune responses to microbial antigens that mimic acetylcholine receptor act as initial triggers of myasthenia gravis? Hum Immunol 2000; 61: 255-265
58. Im SH, Barchan D, Feferman T, et al. Protective molecular mimicry in experimental myasthenia gravis. J Neuroimmunol 2002; 126: 99-106
59. Sigal LH. Lyme disease: A review of aspects of its immunology and immunopathogenesis. Annu Rev Immunol 1997; 15: 63-92
60. Sigal LH, Tatum AH. Lyme disease patients' serum contains IgM antibodies to borrelia burgdorferi that cross-react with neuronal antigens. Neurology 1988; 38: 1439-1442
61. Wang WZ, Fredrikson S, Sun JB, et al. Lyme neuroborreliosis: Evidence for persistent up-regulation of borrelia burgdorferi-reactive cells secreting interferon-gamma. Scand J Immunol 1995; 42: 694-700
62. Garcia-Monco JC, Coleman JL, Benach JL. Antibodies to myelin basic protein in Lyme disease. J Infect Dis 1988; 158: 667-668
63. Sigal LH. Cross-reactivity between Borrelia burgdorferi flagellin and a human axonal 64,000 molecular weight protein. J Infect Dis 1993; 167: 1372-1378
64. Dai Z, Lackland H, Stein S, et al. Molecular mimicry in Lyme disease: Monoclonal antibody H9724 to B. burgdorferi flagellin specifically detects chaperonin-HSP60. Biochim Biophys Acta 1993; 1181: 97-100
65. Fikrig E, Berland R, Chen M, et al. Serologic response to the Borrelia burgdorferi flagellin demonstrates an epitope common to a neuroblastoma cell line. Proc Natl Acad Sci U S A 1993; 90: 183-187
66. Sigal LH, Williams S. A monoclonal antibody to Borrelia burgdorferi flagellin modifies neuroblastoma cell neuritogenesis in vitro: A possible role for autoimmunity in the neuropathy of Lyme disease. Infect Immun 1997; 65: 1 722-1728
67. Alaedini A, Latov N. Antibodies against OspA epitopes of borrelia burgdorferi cross-react with neural tissue. J Neuroimmunol 2005; 159: 192-195
68. Hemmer B, Gran B, Zhao Y, et al. Identification of candidate T-cell epitopes and molecular mimics in chronic Lyme disease. Nat Med 1999; 5: 1375-1382
69. Steiner I. Treating post Lyme disease: Trying to solve one equation with too many unknowns. Neurology 2003; 60: 1888-1889
70. Kurlan R. Tourette's syndrome and 'PANDAS': Will the relation bear out? Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection. Neurology 1998; 50: 1530-1534
71. Snider LA, Swedo SE. Post-streptococcal autoimmune disorders of the central nervous system. Curr Opin Neurol 2003; 16: 359-365
72. Bronze MS, Dale JB. Epitopes of streptococcal M proteins that evoke antibodies that cross-react with human brain. J Immunol 1993; 151: 2820-2828
73. Husby G, van de Rijn I, Zabriskie JB, et al. Antibodies reacting with cytoplasm of subthalamic and caudate nuclei neurons in chorea and acute rheumatic fever. J Exp Med 1976; 144: 1094-1110
74. Kirvan CA, Swedo SE, Heuser JS, et al. Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat Med 2003; 9: 914-920
75. Hoffman KL, Hornig M, Yaddanapudi K, et al. A murine model for neuropsychiatric disorders associated with group A beta-hemolytic streptococcal infection.; Neurosci2004; 24: 1780-1791
76. Singer HS, Giuliano JD, Hansen BH, et al. Antibodies against human putamen in children with Tourette syndrome. Neurology 1998; 50: 1618-1624
77. Pavone P, Bianchini R, Parano E, et al. Anti-brain antibodies in PANDAS versus uncomplicated streptococcal infection. Pediatr Neurol 2004; 30: 107-110
78. Singer HS, Loiselle CR, Lee O, et al. Anti-basal ganglia antibodies in PANDAS. Mov Disord 2004; 19: 406-415
79. Morshed SA, Parveen S, Leckman JF, et al. Antibodies against neural, nuclear, cytoskeletal, and streptococcal epitopes in children and adults with Tourette's syndrome, Sydenham's chorea, and autoimmune disorders. Biol Psychiatry 2001; 50: 566-577
80. Redmond R, Wilson R. Neurological manifestations of AIDS. J Am Optom Assoc 1990; 61: 760-767
81. Silva AA, Camara V, Quirico-Santos T. Intrathecal reactivity for myelin components precedes development of neurological symptoms in AIDS patients. Arch Med Res 1997; 28: 391-396
82. Mastroianni CM, Liuzzi GM, Vullo V, et al. Detection of cerebrospinal fluid antibodies against myelin basic protein in patients with AIDS dementia complex. Mol Chem Neuropathol 1991; 14: 227-236
83. Yamada M, Zurbriggen A, Oldstone MB, et al. Common immunologic determinant between human immunodeficiency virus type 1 gp41 and astrocytes. J Virol 1991; 65: 1370-1376
84. Lolli F, Colao MG, De Maio E, et al. Intrathecal synthesis of anti-HIV antibodies in AIDS patients. J Neurol Sci 1990; 99: 281-289
85. Spehar T, Strand M. Molecular mimicry between HIV-1 gp41 and an astrocyte isoform of alpha-actinin. J Neurovirol 1995; 1: 381-390
86. Trujillo JR, McLane MF, Lee TH, et al. Molecular mimicry between the human immunodeficiency virus type 1 gp120 V3 loop and human brain proteins. J Virol 1993; 67; 7711-7715
87. Durrani OM, Meads CA, Murray PI. Uveitis: A potentially blinding disease. Ophthalmologica 2004; 218: 223-236
88. Martin TM, Kurz DE, Rosenbaum JT. Genetics of uveitis. Ophthalmol Clin North Am 2003; 16: 555-565
89. de Smet MD, Yamamoto JH, Mochizuki M, et al. Cellular immune responses of patients with uveitis to retinal antigens and their fragments. Am J Ophthalmol 1990; 110: 135-142
90. Doekes C, van der Gaag R, Rothova A, et al. Humoral and cellular immune responsiveness to human S-antigen in uveitis. Curr Eye Res 1987; 6: 909-919
91. Singh VK, Yamaki K, Abe T, et al. Molecular mimicry between uveitopathogenic site of retinal S-antigen and Escherichia coli protein: induction of experimental autoimmune uveitis and lymphocyte cross-reaction. Cell Immunol 1989; 122: 262-273
92. Singh VK, Kalra HK, Yamaki K, et al. Molecular mimicry between a uveitopathogenic site of S-antigen and viral peptides. Induction of experimental autoimmune uveitis in Lewis rats. J Immunol 1990; 144: 1282-1287
93. Wildner C, Diedrichs-Mohring M. Autoimmune uveitis induced by molecular mimicry of peptides from rotavirus, bovine casein and retinal S-antigen. Eur J Immunol 2003; 33: 2577-2587
94. Lashkevich VA, Koroleva GA, Lukashev AN, et al. Enterovirus uveitis. Rev Med Virol 2004; 14: 241-254
95. Soares MB, Santos RR. Immunopathology of cardiomyopathy in the experimental Chagas disease. Mem Inst Oswaldo Cruz 1999; 94 (Supple. 1): S257-S262
96. Leon JS, Engman DM. The significance of autoimmunity in the pathogenesis of Chagas heart disease. Front Biosci 2003; 8: e315-e322
97. Meneghelli UC. Chagasic enteropathy. Rev Soc Bras Med Trop 2004; 37: 252-260
98. van Voorhis WC, Eisen H. FI-160. A surface antigen of Trypanosoma cruzi that mimics mammalian nervous tissue. J Exp Med 1989; 169: 641-652
99. van Voorhis WC, Barrett L, Koelling R, et al. FL-160 proteins of Trypanosoma cruzi are expressed from a multigene family and contain two distinct epitopes that mimic nervous tissues. J Exp Med 1993; 178: 681-694
100. van Voorhis WC, Schlekewy L, Trong HL. Molecular mimicry by Trypanosoma cruzi: The F1-160 epitope that mimics mammalian nerve can be mapped to a 12-amino acid peptide. Proc Natl Acad Sci U S A 1991; 88: 5993-5997
101. Retry K, Eisen H. Chemical characterization of epitopes common to Trypanosoma cruzi and mammalian nervous cells. Mem Inst Oswaldo Cruz 1988; 83 (Supple. 1): S498-S501
102. Cea S, Ordonez P, Cerban F, et al. Chagas' disease cardioneuropathy: Association of anti-Trypanosoma cruzi and anti-sciatic nerve antibodies. Am J Trop Med Hyg 1993; 49: 581-588
103. Miller SD, Vanderlugt CL, Begolka WS, et al. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat Med 1997; 3: 1133-1136